Progress with cryopreservation techniques have enabled development of the deferred frozen-thawed embryo transfer (DET) strategy as an alternative to relying on fresh embryo transfers.
With DET, the entire embryo cohort is cryopreserved, and embryo transfer is then performed in a subsequent cycle that takes place separately from the controlled ovarian stimulation (COS).
Initially developed to limit the risk of ovarian hyperstimulation syndrome that occurs with high responders, this strategy has been applied extensively with other populations in an effort to improve implantation rates. The assumption is that COS, which is essential for in vitro fertilization/intra cytoplasmic sperm injection (IVF/ICSI) procedures to obtain a multi-follicular development, could have a detrimental impact on the endometrium as a result of greatly elevated levels of steroids. It is currently not clear whether the DET strategy can be generally applied to all women requiring an IVF/ICSI procedure.
The objectives of this literature review regarding DET, were hence: (i) to present the scientific background that contributed to extensive adoption of this technique, (ii) to detail the pregnancy outcomes and potential obstetric and neonatal consequences, (iii) to report on its ability to prevent risks induced by COS, and (iv) to propose indications for the DET strategy in clinical practice.
KupkaM.S., FerrarettiA.P., de MouzonJ.European IVF-Monitoring Consortium, for the European Society of Human Reproduction and Embryology. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE†. Hum Reprod.2014; 29(10): 2099–2113.
PandianZ., TempletonA., SerourG., BhattacharyaS.Number of embryos for transfer after IVF and ICSI: a Cochrane review. Hum Reprod.2005; 20(10): 2681–2687.
4.
WongK.M., MastenbroekS., ReppingS.Cryopreservation of human embryos and its contribution to in vitro fertilization success rates. Fertil Steril.2014; 102(1): 19–26.
5.
BjurestenK., LandgrenB-M, HovattaO., Stavreus-EversA.Luteal phase progesterone increases live birth rate after frozen embryo transfer. Fertil Steril.2011; 95(2): 534–537.
6.
GroenewoudE.R., CantineauA.E.P., KollenB.J., MacklonN.S., CohlenB.J.What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update.2013; 19(5): 458–470.
7.
BodriD., GuillénJ.J., TrullenqueM., SchwennK., EsteveC., CollO.Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study. Fertil Steril.2010; 93(7): 2418–2420.
8.
ManzanaresM.A., Gómez-PalomaresJ.L., RicciarelliE., HernándezE.R.Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels. Fertil Steril.2010; 93(4): 1215–1219.
9.
EvansJ., HannanN.J., EdgellT.A.Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence. Hum Reprod Update.2014; 20(6): 808–821.
10.
Rodriguez-PurataJ., LeeJ., WhitehouseM.Reproductive outcome is optimized by genomic embryo screening, vitrification, and subsequent transfer into a prepared synchronous endometrium. J Assist Reprod Genet.2016; 33(3): 401–412.
11.
VenetisC.A., KolibianakisE.M., BosdouJ.K., TarlatzisB.C.Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update.2013; 19(5): 433–457.
12.
de ZieglerD., PirteaP., GallianoD., CicinelliE., MeldrumD.Optimal uterine anatomy and physiology necessary for normal implantation and placentation. Fertil Steril.2016; 105(4): 844–854.
NikasG., DeveliogluO.H., TonerJ.P., JonesH.W.Jr.Endometrial pinopodes indicate a shift in the window of receptivity in IVF cycles. Hum Reprod.1999; 14(3): 787–792.
15.
LiuY., LeeK-F, NgE.H.Y., YeungW.S.B., HoP-CGene expression profiling of human peri-implantation endometria between natural and stimulated cycles. Fertil Steril.2008; 90(6): 2152–2164.
16.
WeinermanR., MainigiM.Why we should transfer frozen instead of fresh embryos: the translational rationale. Fertil Steril.2014; 102(1): 10–18.
17.
SalamonsenL.A., NieG., HannanN.J., DimitriadisE.Society for Reproductive Biology Founders Lecture 2009. Preparing fertile soil: the importance of endometrial receptivity. Reprod Fertil Dev.2009; 21(7): 923–934.
18.
CasperR.F., YanushpolskyE.H.Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support. Fertil Steril.2016; 105(4): 867–872.
19.
NoyesR.W., HertigA.T., RockJ.Dating the endometrial biopsy. Am J Obstet Gynecol.1975; 122(2): 262–263.
20.
UbaldiF., BourgainC., TournayeH., SmitzJ., Van SteirteghemA., DevroeyP.Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril.1997; 67(3): 521–526.
21.
LassA., PeatD., AveryS., BrinsdenP.Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist-follicle stimulating hormone ovulation induction for in-vitro fertilization. Hum Reprod.1998; 13(11): 3203–3205.
22.
ZapantisG., SzmygaM.J., RybakE.A., MeierU.T.Premature formation of nucleolar channel systems indicates advanced endometrial maturation following controlled ovarian hyperstimulation. Hum Reprod.2013; 28(12): 3292–3300.
23.
BoomsmaC.M., KavelaarsA., EijkemansM.J.C., FauserBCJM, HeijnenC.J., MacklonN.S.Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo. Fertil Steril.2010; 94(5): 1764–1768.
24.
MirkinS., NikasG., HsiuJ-G, DíazJ., OehningerS.Gene expression profiles and structural/functional features of the peri-implantation endometrium in natural and gonadotropin-stimulated cycles. J Clin Endocrinol Metab.2004; 89(11): 5742–5752.
25.
HorcajadasJ.A., RiesewijkA., PolmanJ.Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod.2005; 11(3): 195–205.
26.
HorcajadasJ.A., MínguezP., DopazoJ.Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications. J Clin Endocrinol Metab.2008; 93(11): 4500–4510.
27.
HaouziD., AssouS., MahmoudK.Gene expression profile of human endometrial receptivity: comparison between natural and stimulated cycles for the same patients. Hum Reprod.2009; 24(6): 1436–1445.
28.
SimonC., OberyéJ., BellverJ.Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod.2005; 20(12): 3318–3327.
29.
LeeJ.Y., LeeM., LeeS.K.Role of endometrial immune cells in implantation. Clin Exp Reprod Med.2011; 38(3): 119–125.
30.
DorfeshanP., SalehniaM., MoazzeniS.M.Ovarian stimulation affects the population of mouse uterine NK cells at early pregnancy. BioMed Res Int2013; 2013: 182531.
31.
JunovichG., MayerY., AzpirozA.Ovarian stimulation affects the levels of regulatory endometrial NK cells and angiogenic cytokine VEGF. Am J Reprod Immunol.2011; 65(2): 146–53.
32.
ParkJ.H., JeeB.C., KimS.H.Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles. Clin Exp Reprod Med.2015; 42(2): 67–71.
33.
LiuL., SailanS., LiT.The effect of a high progesterone concentration before oocyte retrieval on the peri-implantation endometrium. Reprod Biomed Online.2015; 31(6): 739–746.
34.
LabartaE., Martínez-ConejeroJ.A., AlamáP.Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod.2011; 26(7): 1813–1825.
35.
LiR., QiaoJ., WangL.MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration. Reprod Biol Endocrinol.2011; 9: 29.
36.
SonigoC., DrayG., RocheC., Cédrin-DurnerinI., HuguesJ-NImpact of high serum progesterone during the late follicular phase on IVF outcome. Reprod Biomed Online.2014; 29(2): 177–186.
37.
ShapiroB.S., DaneshmandS.T., GarnerF.C., AguirreM., HudsonC., ThomasS.Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril.2011; 96(2): 344–348.
38.
ShapiroB.S., DaneshmandS.T., GarnerF.C., AguirreM., HudsonC., ThomasS.Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders. Fertil Steril.2011; 96(2): 516–518.
39.
RoqueM., LattesK., SerraS.Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril.2013; 99(1): 156–162.
40.
ShapiroB.S., DaneshmandS.T., RestrepoH., GarnerF.C., AguirreM., HudsonC.Matched-cohort comparison of single-embryo transfers in fresh and frozen-thawed embryo transfer cycles. Fertil Steril.2013; 99(2): 389–392.
41.
ShapiroB.S., DaneshmandS.T., GarnerF.C., AguirreM., HudsonC.Freeze-all can be a superior therapy to another fresh cycle in patients with prior fresh blastocyst implantation failure. Reprod Biomed Online.2014; 29(3): 286–290.
42.
AflatoonianA., OskouianH., AhmadiS., OskouianL.Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial. J Assist Reprod Genet.2010; 27(7): 357–363.
43.
HealyM.W., PatounakisG., ConnellM.T.Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles?Fertil Steril.2016; 105(1): 93–9. e1.
44.
ÖzgürK., BerkkanoĝluM., BulutH., IsikliA., CoetzeeK.Higher clinical pregnancy rates from frozen-thawed blastocyst transfers compared to fresh blastocyst transfers: a retrospective matched-cohort study. J Assist Reprod Genet.2015; 32(10): 1483–1490.
45.
ChenZ-J, ShiY., SunY.Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome. N Engl J Med.2016; 375(6): 523–533.
MohamedA.M.F., ChouliarasS., JonesC.J.P., NardoL.G.Live birth rate in fresh and frozen embryo transfer cycles in women with endometriosis. Eur J Obstet Gynecol Reprod Biol.2011; 156(2): 177–180.
48.
BorgheseB., MondonF., NoëlJ-CGene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Mol Endocrinol.2008; 22(11): 2557–2562.
SurreyE.S., SilverbergK.M., SurreyM.W., SchoolcraftW.B.Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril.2002; 78(4): 699–704.
51.
de ZieglerD., GayetV., AubriotF.X.Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril.2010; 94(7): 2796–2799.
52.
LeyendeckerG., BilgicyildirimA., InackerM.Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study. Arch Gynecol Obstet.2015; 291(4): 917–932.
53.
ChapronC., TostiC., MarcellinL.Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes. Hum Reprod.2017 [in press].
54.
VercelliniP., ConsonniD., DridiD., BraccoB., FrattaruoloM.P., SomiglianaE.Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod Oxf Engl.2014; 29(5): 964–977.
55.
ParkC.W., ChoiM.H., YangK.M., SongI.O.Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment. Clin Exp Reprod Med.2016; 43(3): 169–73.
56.
NiuZ., ChenQ., SunY., FengY.Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol.2013; 29(12): 1026–1030.
57.
SantulliP., BourdonM., PresseM.Endometriosis-related infertility: assisted reproductive technology has no adverse impact on pain or quality-of-life scores. Fertil Steril.2016; 105(4): 978–987. e4.
58.
BourdonM., SantulliP., de ZieglerD.Does GnRH Agonist Triggering Control Painful Symptom Scores During Assisted Reproductive Technology? A Retrospective Study. Reprod Sci.2017 Jan 1: 1933719116687659. doi: 10.1177/1933719116687659. [Epub ahead of print].
59.
ZhuD., ZhangJ., CaoS.Vitrified-warmed blastocyst transfer cycles yield higher pregnancy and implantation rates compared with fresh blastocyst transfer cyclestime for a new embryo transfer strategy?Fertil Steril.2011; 95(5): 1691–1695.
60.
OzgurK., BerkkanogluM., BulutH., HumaidanP., CoetzeeK.Perinatal outcomes after fresh versus vitrified-warmed blastocyst transfer: retrospective analysis. Fertil Steril.2015; 104(4): 899–907 e3.
61.
FangC., HuangR., WeiL-N, JiaL.Frozen-thawed day 5 blastocyst transfer is associated with a lower risk of ectopic pregnancy than day 3 transfer and fresh transfer. Fertil Steril.2015; 103(3): 655–661. e3.
62.
HuangB., HuD., QianK.Is frozen embryo transfer cycle associated with a significantly lower incidence of ectopic pregnancy? An analysis of more than 30,000 cycles. Fertil Steril.2014; 102(5): 1345–1349.
63.
LondraL., MoreauC., StrobinoD., GarciaJ., ZacurH., ZhaoY.Ectopic pregnancy after in vitro fertilization: differences between fresh and frozen-thawed cycles. Fertil Steril.2015; 104(1): 110–118.
64.
ChengL-Y, LinP-Y, HuangF-JEctopic pregnancy following in vitro fertilization with embryo transfer: A single-center experience during 15 years. Taiwan J Obstet Gynecol.2015; 54(5): 541–545.
65.
Santos-RibeiroS., TournayeH., PolyzosN.P.Trends in ectopic pregnancy rates following assisted reproductive technologies in the UK: a 12-year nationwide analysis including 160 000 pregnancies. Hum Reprod.2016; 31(2): 393–402.
66.
MaheshwariA., PandeyS., ShettyA., HamiltonM., BhattacharyaS.Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril.2012; 98(2): 368–377. e1–9.
67.
WennerholmU-B, HenningsenA-KA, RomundstadL.B.Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from the CoNARTaS group. Hum Reprod.2013; 28(9): 2545–2553.
68.
IshiharaO., ArakiR., KuwaharaA., ItakuraA., SaitoH., AdamsonG.D.Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single embryo transfer cycles from 2008 to 2010 in Japan. Fertil Steril.2014; 101(1): 128–133.
69.
NakashimaA., ArakiR., TaniH.Implications of assisted reproductive technologies on term singleton birth weight: an analysis of 25,777 children in the national assisted reproduction registry of Japan. Fertil Steril.2013; 99(2): 450–455.
70.
SchwarzeJ-E, CrosbyJ.A., Zegers-HochschildF.Effect of embryo freezing on perinatal outcome after assisted reproduction techniques: lessons from the Latin American Registry of Assisted Reproduction. Reprod Biomed Online.2015; 31(1): 39–43.
71.
PinborgA., HenningsenA.A., LoftA., MalchauS.S., FormanJ., AndersenA.N.Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique?Hum Reprod.2014; 29(3): 618–627.
72.
KaserD.J., MelamedA., BormannC.L.Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil Steril.2015; 103(5): 1176–84. e2.
73.
OpdahlS., HenningsenA.A., TiitinenA.Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod.2015; 30(7): 1724–1731.
74.
JärveläI.Y., PelkonenS., UimariO.Controlled ovarian hyperstimulation leads to high progesterone and estradiol levels during early pregnancy. Hum Reprod.2014; 29(11): 2393–2401.
75.
SunkaraS.K., La MarcaA., SeedP.T., KhalafY.Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes. Hum Reprod.2015; 30(6): 1473–1480.
76.
PelkonenS., GisslerM., KoivurovaS.Physical health of singleton children born after frozen embryo transfer using slow freezing: a 3-year follow-up study. Hum Reprod.2015; 30(10): 2411–2418.
77.
de ZieglerD., GamboneJ.C., MeldrumD.R., ChapronC.Risk and safety management in infertility and assisted reproductive technology (ART): from the doctors office to the ART procedure. Fertil Steril.2013; 100(6): 1509–1517.
78.
SmithV., OsianlisT., VollenhovenB.Prevention of ovarian hyperstimulation syndrome: a review. Obstet Gynecol Int.2015; 2015: 514159.
FatemiH.M., Garcia-VelascoJ.Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger. Fertil Steril.2015; 103(4): 870–873.
81.
YoussefMAFM, Van der VeenF., Al-InanyH.G.Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev.2014; 10(10): CD008046.
82.
HumaidanP., EngmannL., BenadivaC.Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches. Fertil Steril.2015; 103(4): 879–885.
83.
ChanW.S.The ART of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol.2009; 21(3): 207–218.
84.
HansenA.T., KesmodelU.S., JuulS., HvasA.M.Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Hum Reprod.2014; 29(3): 611–617.
85.
HenrikssonP., WesterlundE., WallénH., BrandtL., HovattaO., EkbomA.Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ.2013; 346: e8632.
86.
RovaK., PassmarkH., LindqvistP.G.Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril.2012; 97(1): 95–100.
87.
OrquevauxP., MasseauA., Le GuernV.[In vitro fertilization and systemic lupus erythematosus or antiphospho-lipid syndrome: an update]. Rev Med Interne.2015; 36(3): 154–158.
88.
TsiamiA., ChaimaniA., MavridisD., SiskouM., AssimakopoulosE., SotiriadisA.Surgical treatment for hydrosalpinx prior to IVF-ET: a network meta-analysis. Ultrasound Obstet Gynecol.2016; 48(4): 434–445.
89.
ScottR.T.Jr., UphamK.M., FormanE.J.Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril.2013; 100(3): 697–703.
90.
RodrigoL., MateuE., MercaderA.New tools for embryo selection: comprehensive chromosome screening by array comparative genomic hybridization. Biomed Res Int.2014; 2014: 517125.
